Prove your product claims with BDD Scintigraphy, best in class scintigraphic clinical trials.
A unique patented time release technology, OralogiK™ provides unrivalled control of drug release at the right place and the right time to achieve a superior and clinically effective drug delivery profile.
BDD SWIFT for rapid clinical development. SWIFT accelerates evaluation and optimisation of product performance using in vivo clinical data to direct formulation design in real time. SWIFT studies enable you to make decisions on formulation changes based on emerging clinical data. This integration of formulation development, GMP manufacturing and clinical testing activities can reduce the time from initial prototype development to clinical results to just 6 months.